Luc Perrin

12.7k total citations · 1 hit paper
160 papers, 9.1k citations indexed

About

Luc Perrin is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Luc Perrin has authored 160 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Virology, 71 papers in Infectious Diseases and 45 papers in Epidemiology. Recurrent topics in Luc Perrin's work include HIV Research and Treatment (81 papers), HIV/AIDS drug development and treatment (51 papers) and HIV/AIDS Research and Interventions (46 papers). Luc Perrin is often cited by papers focused on HIV Research and Treatment (81 papers), HIV/AIDS drug development and treatment (51 papers) and HIV/AIDS Research and Interventions (46 papers). Luc Perrin collaborates with scholars based in Switzerland, United States and United Kingdom. Luc Perrin's co-authors include Sabine Yerly, Bernard Hirschel, Didier Trono, Marc Friedli, Gersende Caron, Priscilla Turelli, Bastien Mangeat, P. A. Miescher, Laurent Kaiser and P H Lambert and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Luc Perrin

160 papers receiving 8.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

2003 1.2k citations Luc Perrin et al. profile →

Peers

Countries citing papers authored by Luc Perrin

Since Specialization

Citations

This map shows the geographic impact of Luc Perrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luc Perrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luc Perrin more than expected).

Fields of papers citing papers by Luc Perrin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luc Perrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luc Perrin. The network helps show where Luc Perrin may publish in the future.

Co-authorship network of co-authors of Luc Perrin

This figure shows the co-authorship network connecting the top 25 collaborators of Luc Perrin. A scholar is included among the top collaborators of Luc Perrin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luc Perrin. Luc Perrin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	More Than 30% HCV Prevalence in the HIV-1 El-Fateh Children Hospital Outbreak is a Key for Both Elucidation and Public Health Measures 2007 ·Libyan Journal of Medicine ·Luc Perrin	3
2	Early induction of leukemia inhibitor factor (LIF) in acute HIV-1 infection 2005 ·AIDS ·Annelie Tjernlund, Babilonia Barqasho, Piotr Nowak, Sabine Kinloch, D. Thorborn, Luc Perrin, Anders Sönnerborg, Lilian Walther–Jallow, Jan Andersson	12
3	Lower Respiratory Viral Illnesses 2004 ·American Journal of Respiratory and Critical Care Medicine ·Jorge Garbino, Margaret W. Gerbase, Werner Wunderli, Christelle Deffernez, Yves Thomas, Thierry Rochat, Béatrice Ninet, Jacques Schrenzel, Sabine Yerly, Luc Perrin, Paola M. Soccal, Laurent Nicod, Laurent Kaiser	110
4	Characterization of genotypic determinants in HR-1 and HR-2 gp41 domains in individuals with persistent HIV viraemia under T-20 2004 ·AIDS ·Anne‐Geneviève Marcelin, Jacques Reynes, Sabine Yerly, Nadine Ktorza, Michel Segondy, (unknown), Jean‐François Delfraissy, Laurent Kaiser, Luc Perrin, Christine Katlama, Vincent Cálvez	29
5	A controlled trial of granulocyte macrophage-colony stimulating factor during interruption of HAART 2003 ·AIDS ·Catherine Fagard, (unknown), Huldrych F. Günthard, Hans H. Hirsch, Matthias Egger, Pietro Vernazza, Enos Bernasconi, Amalio Telenti, (unknown), Annette Oxenius, Thomas Perneger, Luc Perrin, Bernard Hirschel	20
6	Prevalence of human T‐cell leukemia virus types I and II in Switzerland 2003 ·Journal of Medical Virology ·Jürg Böni, Leslie R. Bisset, Johann Jakob Burckhardt, Helen I. Joller‐Jemelka, Philippe Bürgisser, Luc Perrin, Meri Gorgievski, Peter Erb, Walter Fierz, J C Piffaretti, Jörg Schüpbach	6
7	Parallel decline of CD8+/CD38++ T cells and viraemia in response to quadruple highly active antiretroviral therapy in primary HIV infection 2002 ·AIDS ·(unknown), Sabine Kinloch, Li‐Ean Goh, David A. Cooper, Luc Perrin, Fiona Lampe, John Zaunders, Bruno Hoën, Chris Tsoukas, Jan Andersson, George Janossy	72
8	Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy 2002 ·AIDS ·Gilbert Greub, Alessandro Cozzi‐Lepri, Bruno Ledergerber, Schlomo Staszewski, Luc Perrin, Veronica Miller, P Francioli, Hansjakob Furrer, Manuel Battegay, Pietro Vernazza, Enos Bernasconi, Huldrych F. Günthard, Bernard Hirschel, Andrew Phillips, Amalio Telenti	95
9	Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load 2002 ·AIDS ·Annette Oxenius, David A. Price, Sara J. Dawson, Huldrych F. Günthard, Marek Fischer, Luc Perrin, (unknown), Catherine Fagard, Bernard Hirschel, G Scullard, Jonathan Weber, Angela R. McLean, Rodney E. Phillips	18
10	A Randomized Trial of Simplified Maintenance Therapy with Abacavir, Lamivudine, and Zidovudine in Human Immunodeficiency Virus Infection 2002 ·The Journal of Infectious Diseases ·Milos Opravil, Bernard Hirschel, Adriano Lazzarin, Hansjakob Furrer, Jean‐Philippe Chave, Sabine Yerly, Leslie R. Bisset, Marek Fischer, Pietro Vernazza, Enos Bernasconi, Manuel Battegay, Bruno Ledergerber, Huldrych F. Günthard, Colin Howe, Rainer Weber, Luc Perrin, (unknown)	106
11	Nosocomial Outbreak of Multiple Bloodborne Viral Infections 2001 ·The Journal of Infectious Diseases ·Sabine Yerly, Rafael Quadri, Francesco Negro, (unknown), Jean‐Jacques Cheseaux, Philippe Bürgisser, Claire‐Anne Siegrist, Luc Perrin	64
12	Decay of cell-associated HIV-1 DNA correlates with residual replication in patients treated during acute HIV-1 infection 2000 ·AIDS ·Sabine Yerly, Thomas Perneger, Samir Vora, Bernard Hirschel, Luc Perrin	86
13	Virus Burden in Lymph Nodes and Blood of Subjects with Primary Human Immunodeficiency Virus Type 1 Infection on Bitherapy 1998 ·The Journal of Infectious Diseases ·Luc Perrin, Sabine Yerly, Francis Marchal, Gérard A. Schockmel, Bernard Hirschel, Cecil H. Fox, Giuseppe Pantaleo	23
14	Detection of Low HIV-1 RNA Levels in Plasma 1997 ·Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology ·Gérard A. Schockmel, Sabine Yerly, Luc Perrin	137
15	Toxicity, efficacy, plasma drug concentrations and protease mutations in patients with advanced HIV infection treated with ritonavir plus saquinavir 1997 ·AIDS ·Patrizio Lorenzi, Sabine Yerly, (unknown), Marc Fathi, Olivier Rutschmann, Jan von Overbeck, Dominique Leduc, Luc Perrin, Bernard Hirschel	96
16	PREVALENCE DE LA TRANSMISSION DE VIRUS RESISTANT A LA ZIDOVUDINE EN SUISSE 1996 ·Schweizerische medizinische Wochenschrift ·Sabine Yerly, (unknown), Sabine Kinloch-de-Loës, Peter Erb, P Vernazza, Bernard Hirschel, Luc Perrin	9
17	Lack of monomeric IgM anti-hepatitis C virus (HCV) core antibodies in patients with chronic HCV infection 1996 ·Journal of Virological Methods ·Francesco Negro, Hugo Troonen, Gerd Michel, Emiliano Giostra, (unknown), Luc Perrin, Antoine Hadengue	6
18	Absence of Chronic Human Immunodeficiency Virus Infection without Seroconversion in Intravenous Drug Users: A Prospective and Retrospective Study 1991 ·The Journal of Infectious Diseases ·Sabine Yerly, Eric Chamot, Jean‐Jacques Déglon, Bernard Hirschel, Luc Perrin	12
19	Development of a haptoglobin ELISA. Its use as an indicator for malaria 1990 ·Acta Tropica ·Sabine Yerly, (unknown), A. Rougemont, I Srivastava, Luc Perrin	12
20	Recombinant polypeptides for serology of malaria 1989 ·Transactions of the Royal Society of Tropical Medicine and Hygiene ·Indresh K. Srivastava, Béla Takács, Patrick Caspers, Ulrich Certa, Ian A. McGregor, John G. Scaife, Luc Perrin	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact